Publications by authors named "Anthony Winiski"

Claim this Profile
S
SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
Shirley Wang, Sabine Olt, Nicole Schoefmann, Anton Stuetz, Anthony Winiski, Barbara Wolff-Winiski

Exp Dermatol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of stearoyl CoA desaturase in the skin induces atrophy of the sebaceous glands.
Josef G Meingassner, Heinrich Aschauer, Anthony P Winiski, Natalie Dales, David Yowe

J Invest Dermatol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship studies on a novel class of antiproliferative agents derived from Lavendustin A. Part I: Ring A modifications.
Peter Nussbaumer, Anthony P Winiski

Bioorg Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of T-cell activation in vitro in human peripheral blood mononuclear cells by pimecrolimus and glucocorticosteroids and combinations thereof.
Anthony Winiski, Shirley Wang, Brigitte Schwendinger, Anton Stuetz

Exp Dermatol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential inhibition of primary versus preactivated T cells by pimecrolimus but not by tacrolimus in vitro.
Frank S Kalthoff, Anthony Winiski, Petra Fichtinger, Brigitte Schwendinger, Shirley Wang

Int Arch Allergy Immunol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicle.
Loïc Tauzin, Christine Graf, Mei Sun, Philipp Rovina, Nicolas Bouveyron, Anthony Winiski

J Lipid Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases.
Andreas Billich, Josef G Meingassner, Peter Nussbaumer, Sandrine Desrayaud, Charles Lam, Anthony Winiski

J Steroid Biochem Mol Biol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
Erwin P Schreiner, Barbara Wolff, Anthony P Winiski, Andreas Billich

Bioorg Med Chem Lett· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Peter Nussbaumer, Anthony P Winiski, Andreas Billich

J Med Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis.
Jesús Medina, Valérie Picarles, Brigitte Greiner, Christian Elsaesser, Maryelle Kolopp, Anthony Winiski

Biochem Pharmacol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis